MBX Biosciences, Inc. Common Stock
MBX Biosciences, Inc. Common Stock (MBX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mbx · stock forecast · 7 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 7 Wall Street analysts in the past 3 months
Buy
7 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$88.00
Consensus
$68.80
+130.4% upside
Low
$56.00
Median: $70 · Last Close: $29.86
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$68.80
130.4% upside
High Target
$88
194.7%
Low Target
$56
87.5%
Current Price
$29.86
as of today
Based on analyst price targets, the MBX stock price prediction for the next 12 months ranges from $56 to $88. The consensus MBX price forecast of $68.80 implies 130.4% upside from the current price of $29.86.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $28.57 | ↓ 4.32% |
1-day model range: $28.29–$28.85. Peak: $28.85 (-4.32%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MBX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Barclays | Maintains | Overweight→Overweight |
| 2026-05-12 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-05-11 | Truist Securities | Maintains | Buy→Buy |
| 2026-01-16 | Guggenheim | Maintains | Buy→Buy |
| 2025-12-19 | Stifel | Maintains | Buy→Buy |
| 2025-11-10 | Guggenheim | Maintains | Buy→Buy |
| 2025-09-24 | Mizuho | Maintains | Outperform→Outperform |
| 2025-09-23 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-09-23 | Guggenheim | Maintains | Buy→Buy |
| 2025-04-10 | Guggenheim | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on MBX Biosciences, Inc. Common Stock (MBX) stock. Of the recent 10 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover MBX.
Analyst Recommendation Trends
MBX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-2.80
EPS Next Year
$-3.91
↑ 39.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast MBX EPS of $-2.80 for the current fiscal year, based on estimates from 8 analysts. The MBX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MBX stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MBX price target is $68.80 (+130.4% upside), with an analyst consensus of Buy.
The MBX short-term stock prediction for tomorrow is $28.57 (-4.32%).
MBX Biosciences, Inc. Common Stock trades on NASDAQ under the ticker MBX. The MBX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
MBX forecast · 8 questionsAccording to 7 Wall Street analysts, the average 12-month MBX price target is $68.80, with a high forecast of $88.00 and a low of $56.00. The median price target is shown in the chart above when available. This implies +130.4% potential upside from the current price of $29.86.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.